(Q54638158)

1 June 2018

title

Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. (English)

1 reference

1 June 2018

0 references

1

1 reference

1 June 2018

Sabine Werner

7

object named as

Sabine Werner

1 reference

1 June 2018

8

Ueli Suter

1 reference

1 June 2018

author name string

Danielle Boller

2

1 reference

1 June 2018

Lukas De Ventura

3

1 reference

1 June 2018

Heidi Koegel

4

1 reference

1 June 2018

Matthias Boentert

5

1 reference

1 June 2018

Peter Young

6

1 reference

1 June 2018

publication date

1 January 2006

1 reference

1 June 2018

published in

Glia

1 reference

1 June 2018

volume

53

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

147-157

1 reference

1 June 2018

Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The protooncogene Ski controls Schwann cell proliferation and myelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The Cell Cycle Inhibitor p21CIPIs Phosphorylated by Cyclin A-CDK2 Complexes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The chemokine receptor CCR1 is strongly up-regulated after skin injury but dispensable for wound healing

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The early life of a Schwann cell

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Schwann cells as regulators of nerve development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Evolving ideas about cyclins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Axons regulate Schwann cell expression of the POU transcription factor SCIP

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

https://api.crossref.org/works/10.1002%2FGLIA.20263

1 reference

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Disease mechanisms in inherited neuropathies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

p21-containing cyclin kinases exist in both active and inactive states

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20263

7 January 2021

Identifiers

DOI

10.1002/GLIA.20263

1 reference

1 June 2018

1 reference

1 June 2018